Surgery, chemoradiotherapy, or chemoradiation plus immunotherapy: Treatment strategies for nonmetastatic anal squamous cell carcinoma

Surgery, chemoradiotherapy, or chemoradiation plus immunotherapy: Treatment strategies for nonmetastatic anal squamous cell carcinoma

The current standard of care for anal squamous cell carcinoma (ASCC) is definitive concurrent chemoradiotherapy (CRT). However, about a third of patients may experience treatment failure. Recently, immunotherapy has emerged as a novel strategy for metastatic ASCC patients. We evaluated the efficacy...

Full description

Saved in:
Bibliographic Details
Main Authors: Fang He, Mo Chen, Qi-jun Yao, Zhi-min Liu, Yandong Zhao, Fengyun Pei, Jian Zheng, Yuan-hong Gao, Jun Huang
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Translational Oncology
Subjects:
Surgery
Chemoradiotherapy
Immunotherapy
Squamous cell carcinoma
Anal canal
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523324002602
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items